Alnylam Pharmaceuticals, Inc. (ALNY)
246.04
+5.35
(+2.22%)
USD |
NASDAQ |
Sep 01, 16:00
245.76
-0.28
(-0.11%)
After-Hours: 17:10
Alnylam Pharmaceuticals Cash and Short Term Investments (Quarterly) : 3.308B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.308B |
| March 31, 2026 | 3.009B |
| December 31, 2025 | 2.908B |
| September 30, 2025 | 2.725B |
| June 30, 2025 | 2.858B |
| March 31, 2025 | 2.632B |
| December 31, 2024 | 2.695B |
| September 30, 2024 | 2.780B |
| June 30, 2024 | 2.625B |
| March 31, 2024 | 2.371B |
| December 31, 2023 | 2.439B |
| September 30, 2023 | 2.406B |
| June 30, 2023 | 2.058B |
| March 31, 2023 | 2.071B |
| December 31, 2022 | 2.192B |
| September 30, 2022 | 2.265B |
| June 30, 2022 | 2.111B |
| March 31, 2022 | 2.240B |
| December 31, 2021 | 2.438B |
| September 30, 2021 | 2.328B |
| June 30, 2021 | 1.900B |
| March 31, 2021 | 1.710B |
| December 31, 2020 | 1.877B |
| September 30, 2020 | 1.834B |
| June 30, 2020 | 1.926B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.342B |
| December 31, 2019 | 1.536B |
| September 30, 2019 | 1.721B |
| June 30, 2019 | 1.927B |
| March 31, 2019 | 1.245B |
| December 31, 2018 | 1.084B |
| September 30, 2018 | 1.237B |
| June 30, 2018 | 1.448B |
| March 31, 2018 | 1.568B |
| December 31, 2017 | 1.691B |
| September 30, 2017 | 948.29M |
| June 30, 2017 | 923.27M |
| March 31, 2017 | 559.60M |
| December 31, 2016 | 626.80M |
| September 30, 2016 | 713.14M |
| June 30, 2016 | 856.40M |
| March 31, 2016 | 1.014B |
| December 31, 2015 | 1.081B |
| September 30, 2015 | 1.016B |
| June 30, 2015 | 1.005B |
| March 31, 2015 | 1.067B |
| December 31, 2014 | 696.69M |
| September 30, 2014 | 631.93M |
| June 30, 2014 | 654.76M |
| March 31, 2014 | 665.49M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.055B |
| BridgeBio Pharma, Inc. | 720.71M |
| Regeneron Pharmaceuticals, Inc. | 8.005B |
| Vertex Pharmaceuticals, Inc. | 7.863B |
| Pfizer Inc. | 11.70B |